Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2053

Biomedical engineers at Duke University have devised a machine learning approach to modeling the interactions between complex variables in engineered bacteria that would otherwise be too cumbersome to predict. Their algorithms are generalizable to many kinds of biological systems.

In the new study, the researchers trained a neural network to predict the circular patterns that would be created by a biological circuit embedded into a bacterial culture. The system worked 30,000 times faster than the existing computational .

To further improve accuracy, the team devised a method for retraining the machine learning model multiple times to compare their answers. Then they used it to solve a second biological system that is computationally demanding in a different way, showing the algorithm can work for disparate challenges.

Read more | >

Despite this economic pressure, rural America remains one of our nation’s most fertile regions, and recent advances in biotechnology are making it easier than ever to sustainably grow new kinds of valuable goods, from biopharmaceuticals to biomaterials. With the right strategic investments, rural America could see a biotech “bloom.”

I propose a Bio-Belt stretching through middle America to bring new skills and high-paying jobs to communities that desperately need them. This initiative would bolster investment in biotechnology training, education, infrastructure and entrepreneurship in rural areas in order to develop new, sustainable sources of income.

The Bio-Belt is about much more than biofuel. Fermentation is an increasingly powerful force for converting sugar and other forms of biomass into value-added goods—all through the rational design of cells that can be sustainably grown wherever land is abundant.

Read more | >

The fruit flies in Noah Whiteman’s lab may be hazardous to your health.

Whiteman and his University of California, Berkeley, colleagues have turned perfectly palatable —palatable, at least, to frogs and birds—into potentially poisonous prey that may cause anything that eats them to puke. In large enough quantities, the flies likely would make a human puke, too, much like the emetic effect of ipecac syrup.

That’s because the team genetically engineered the flies, using CRISPR-Cas9 gene editing, to be able to eat milkweed without dying and to sequester its toxins, just as America’s most beloved butterfly, the , does to deter predators.

Read more | >

Scientists have unraveled the biological mechanisms behind what they describe as the extraordinary “superpower” ability of jellyfish to regenerate body parts.

Jellyfish are primitive animals which evolved in the oceans around 600 million years ago. Part of the reason for their evolutionary success is that some species are able to grow back tissue that has been lost—a trait that is rare in the animal kingdom.

To learn more about this poorly understood ability, a team of researchers from Tohoku University in Japan investigated the biology of a jellyfish species known as Cladonema pacificum—which has tentacles that spread out like tree branches—for a study published in the journal PeerJ.

Read more | >

Today, we have launched the MitoMouse project on our fundraising platform Lifespan.io. This project aims to reverse the damage that aging does to the mitochondrial DNA and to restore energy production in our cells with the goal of preventing age-related ill health.

The power stations of the cell

The mitochondria are the power stations of every single cell in our bodies, and they are responsible for converting the nutrients we absorb into energy. The mitochondria are so efficient at doing this that they are responsible for around 90% of the energy that our cells need to function and survive.

Read more | >

A role for the gut microbiome on the health and functioning of many tissues, including the brain, liver, kidney, and adiposity, has been widely reported in the literature. Interestingly, 2019 might be the year that the role of the gut microbiome on skeletal muscle (i.e. the gut-muscle axis) comes into greater focus.

The influence of the gut microbiome on muscle strength

In April, Nay et al. reported that endurance exercise capacity was reduced in mice that do not contain a microbiome (germ-free mice, GFM) when compared with conventionally raised, microbiome-containing mice. This finding suggests that there are microbes in the gut that positively influence aerobic exercise performance.

Read more | >

Checkerspot, a biotech startup using microalgae to produce performance materials, announced today that it has closed its Series A financing for $13 million. The round was led by Builders VC, and included Breakout Ventures, Viking Global Investors, KdT Ventures, Plug and Play Ventures, Sahsen Ventures, and Godfrey Capital, among others.

Checkerspot combines bioengineering, chemistry, and materials science to go from microalgae to next-generation performance materials.

“This is a pretty significant milestone for us,” said Checkerspot CEO Charles Dimmler. He said the funding would support the company’s continued infrastructure development, as well as ongoing commercial activities with Beyond Surface Technologies and DIC that focus on novel triglycerides and polyols. He also said it would help complete the development of a direct-to-consumer product later this year.

Read more | >

When I imagine the inner workings of a robot, I think hard, cold mechanics running on physics: shafts, wheels, gears. Human bodies, in contrast, are more of a contained molecular soup operating on the principles of biochemistry.

Yet similar to robots, our cells are also attuned to mechanical forces—just at a much smaller scale. Tiny pushes and pulls, for example, can urge stem cells to continue dividing, or nudge them into maturity to replace broken tissues. Chemistry isn’t king when it comes to governing our bodies; physical forces are similarly powerful. The problem is how to tap into them.

In a new perspectives article in Science, Dr. Khalid Salaita and graduate student Aaron Blanchard from Emory University in Atlanta point to DNA as the solution. The team painted a futuristic picture of DNA mechanotechnology, in which we use DNA machines to control our biology. Rather than a toxic chemotherapy drip, for example, a cancer patient may one day be injected with DNA nanodevices that help their immune cells better grab onto—and snuff out—cancerous ones.

Read more | >